Cite
MLA Citation
Abraham M. Varghese et al.. “Eradication of minimal residual disease improves overall and progression‐free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation.” British journal of haematology, vol. 176, 2017, pp. 573–582. http://access.bl.uk/ark:/81055/vdc_100041767516.0x000035